FDA Approves Leucovorin for Autism Treatment

Source: F.D.A. to Relabel Leucovorin for Autism Treatment (2025-09-22)

The FDA has approved leucovorin as a treatment for children with autism spectrum disorder (ASD), marking a significant development in autism therapeutics. The decision follows clinical trials demonstrating that leucovorin can improve social and communication skills in some children with ASD, offering a new option for families seeking targeted interventions. Researchers highlight that leucovorin, a form of folate, appears to modulate brain chemistry related to autism symptoms. While not a cure, the medication provides hope for personalized treatment approaches, though experts caution that further studies are needed to understand long-term effects and identify which patients are most likely to benefit.

More recent coverage

• Jake Paul vs. Gervonta Davis Fight Announced
• Jones Links Up with McCaffrey for Big Gain
• Tragic Loss: Jocelynn Krauss Passes Away at 21
• GWAR Performs Mock Beheading of Elon Musk at Riot Fest
• Philippines Anti-Corruption Protests Turn Violent
• Einstein's Handwritten Entry Could Sell for $200,000
• AFL Finals Spotlight: Daicos and Ashcroft Aim for Greatness
• New Queer Love Story "Whisperings of the Moon" Debuts